Medical Endocrinology PE 2132, Rigshospitalet

Copenhagen 2100

0 studies enrolling now · 1 studies all time

What they study most

Fabry Disease

Studies at this site

• Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients — Completed